216 related articles for article (PubMed ID: 20144595)
1. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.
Liu CC; Huang SP; Tsai LY; Wu WJ; Juo SH; Chou YH; Huang CH; Wu MT
Clin Chim Acta; 2010 May; 411(9-10):739-43. PubMed ID: 20144595
[TBL] [Abstract][Full Text] [Related]
2. Association of vitamin D receptor (Fok-I) polymorphism with the clinical presentation of calcium urolithiasis.
Liu CC; Huang CH; Wu WJ; Huang SP; Chou YH; Li CC; Chai CY; Wu MT
BJU Int; 2007 Jun; 99(6):1534-8. PubMed ID: 17419705
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.
Amar A; Afzal A; Hameed A; Ahmad M; Khan AR; Najma H; Abid A; Khaliq S
BMC Med Genet; 2020 Aug; 21(1):172. PubMed ID: 32842990
[TBL] [Abstract][Full Text] [Related]
4. The impact of cigarette smoking, alcohol drinking and betel quid chewing on the risk of calcium urolithiasis.
Liu CC; Huang SP; Wu WJ; Chou YH; Juo SH; Tsai LY; Huang CH; Wu MT
Ann Epidemiol; 2009 Aug; 19(8):539-45. PubMed ID: 19375945
[TBL] [Abstract][Full Text] [Related]
5. Heterozygote AG variant of -596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL).
Vasku JA; Vasku A; Goldbergova M; Vasku V
Clin Immunol; 2004 Dec; 113(3):256-60. PubMed ID: 15507390
[TBL] [Abstract][Full Text] [Related]
6. The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease.
Rhee EJ; Oh KW; Lee WY; Kim SY; Jung CH; Kim BJ; Sung KC; Kim BS; Kang JH; Lee MH; Kim SW; Park JR
Metabolism; 2006 Oct; 55(10):1344-51. PubMed ID: 16979405
[TBL] [Abstract][Full Text] [Related]
7. OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis.
Tugcu V; Simsek A; Tarhan T; Atalar F; Bitkin A; Tasci AI; Kural AR; Altug T
Ren Fail; 2013 Jul; 35(6):825-9. PubMed ID: 23692545
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.
Chen YJ; Shen JL; Wu CY; Chang YT; Chen CM; Lee FY
J Am Acad Dermatol; 2009 Feb; 60(2):225-30. PubMed ID: 19028408
[TBL] [Abstract][Full Text] [Related]
9. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
10. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
11. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
12. Roles of osteopontin gene polymorphism (rs1126616), osteopontin levels in urine and serum, and the risk of urolithiasis: a meta-analysis.
Li X; Liu K; Pan Y; Zhang J; Lv Q; Hua L; Wang Z; Li J; Yin C
Biomed Res Int; 2015; 2015():315043. PubMed ID: 25785266
[TBL] [Abstract][Full Text] [Related]
13. Urinary melamine and adult urolithiasis in Taiwan.
Wu CF; Liu CC; Chen BH; Huang SP; Lee HH; Chou YH; Wu WJ; Wu MT
Clin Chim Acta; 2010 Feb; 411(3-4):184-9. PubMed ID: 19900434
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 promoter polymorphisms in patients with Behçet's disease.
Lee YJ; Kang SW; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Hum Immunol; 2006 Oct; 67(10):812-8. PubMed ID: 17055358
[TBL] [Abstract][Full Text] [Related]
15. Association between the T-593A and C6982T polymorphisms of the osteopontin gene and risk of developing nephrolithiasis.
Gögebakan B; Igci YZ; Arslan A; Igci M; Erturhan S; Oztuzcu S; Sen H; Demiryürek S; Arikoglu H; Cengiz B; Bayraktar R; Yurtseven C; Sarıca K; Demiryürek AT
Arch Med Res; 2010 Aug; 41(6):442-8. PubMed ID: 21044748
[TBL] [Abstract][Full Text] [Related]
16. Association of vitamin D receptor gene Taq I polymorphism with recurrent urolithiasis in children.
Seyhan S; Yavascaoglu I; Kilicarslan H; Dogan HS; Kordan Y
Int J Urol; 2007 Dec; 14(12):1060-2. PubMed ID: 18036039
[TBL] [Abstract][Full Text] [Related]
17. Association between Osteopontin Promoter Gene Polymorphisms and Haplotypes with Risk of Diabetic Nephropathy.
Cheema BS; Iyengar S; Sharma R; Kohli HS; Bhansali A; Khullar M
J Clin Med; 2015 Jun; 4(6):1281-92. PubMed ID: 26239559
[TBL] [Abstract][Full Text] [Related]
18. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study.
Rivadeneira F; Houwing-Duistermaat JJ; Beck TJ; Janssen JA; Hofman A; Pols HA; Van Duijn CM; Uitterlinden AG
J Bone Miner Res; 2004 Aug; 19(8):1280-90. PubMed ID: 15231015
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels.
Ceelie H; Bertina RM; van Hylckama Vlieg A; Rosendaal FR; Vos HL
Thromb Haemost; 2001 Jun; 85(6):1066-70. PubMed ID: 11434686
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
Medina-Franco H; Ramos-De la Medina A; Vizcaino G; Medina-Franco JL
Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
